Generation Bio
GBIO
GBIO
91 hedge funds and large institutions have $364M invested in Generation Bio in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.21% less ownership
Funds ownership: 9.91% → 9.7% (-0.21%)
13% less capital invested
Capital invested by funds: $416M → $364M (-$52.3M)
Holders
91
Holding in Top 10
1
Calls
$111K
Puts
$1K
Top Buyers
| 1 | +$14.4M | |
| 2 | +$2.19M | |
| 3 | +$1.41M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.1M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$917K |
Top Sellers
| 1 | -$9.72M | |
| 2 | -$8.78M | |
| 3 | -$8.23M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$3.95M |
| 5 |
Two Sigma Investments
New York
|
-$678K |